American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • 2017

Collegiate Inventors Competition names graduate, undergraduate winners

American Pharmacy News Reports | Jan 3, 2017
The Collegiate Inventors Competition recently named its 2016 winners.

The 2016 graduate and undergraduate student winners of the Collegiate Inventors Competition included inventions and innovations presented at the competition including the administration of therapeutic drugs at-home and engineered biological particles that destroy pesticides in residual crops. Read More »

Boehringer Ingelheim releases INVICTAN-1 trial data

American Pharmacy News Reports | Jan 3, 2017
The INVICTAN-1 trial involved BI 695502.

Boehringer Ingelheim has released data from its Phase I INVICTAN-1 trial involving BI 695502, the company’s bevacizumab biosimilar candidate, which shows that the drug is a bioequivalent of Avastin, which is licensed in the U.S. and E.U. Read More »

FDA approves Intrarosa for moderate to severe pain during intercourse

American Pharmacy News Reports | Jan 3, 2017
Intrarosa has been approved to treat postmenopausal women who experience pain during sex.

Intrarosa (prasterone), which is designed for women who experience moderate to severe pain during sex, has been approved by the U.S. Food and Drug Administration. Read More »

AzurRx teams with Mayoly Spindler for Phase II drug trial

American Pharmacy News Reports | Jan 3, 2017
The Phase II clinical trial will assess the safety and effectiveness of MS1819-SD for the treatment of patients who have exocrine pancreatic insufficiency.

AzurRx BioPharma has partnered with Mayoly Spindler to begin a Phase II clinical trial to assess the safety and effectiveness of MS1819-SD for the treatment of patients who have exocrine pancreatic insufficiency that is the result of chronic pancreatitis. Read More »

AcelRx presents ARX-04 data at ASRA annual meeting

American Pharmacy News Reports | Jan 3, 2017
The presentation featured the first data presented from the ARX-04 trial.

AcelRx Pharmaceuticals presented results from its Phase 3 SAP303 study of ARX-04 at the 15th Annual Pain Medicine Meeting of the American Society of Regional Anesthesia and Pain Medicine. Read More »

Rebiotix treats first patient with microbe capsule

American Pharmacy News Reports | Jan 4, 2017

The biotech company Rebiotix Inc. recently announced that a patient has been treated for the first time with a capsule that delivers live microbes into the human intestinal tract. Read More »

Avella moves corporate headquarters to Phoenix

American Pharmacy News Reports | Jan 4, 2017
The move into the Phoenix facility will allow Avella to house its clinical, operational and administrative processes in one location.

Avella has moved its operations to a new 50,000-square-foot corporate headquarters in Phoenix. Read More »

Veloxis establishes warrant program for employees, board members

American Pharmacy News Reports | Jan 4, 2017
The total number of warrants awarded will be just over 2.8 million, which will give the right to subscription at $0.10 each.

Veloxis Pharmaceuticals will establish a warrant program for its board members and its employees with the Veloxis Board of Directors exercising, in part, an authorization pursuant to the Articles of Association. Read More »

Zynex expects to post $15 million in revenue for 2016

American Pharmacy News Reports | Jan 4, 2017
Zynex manufactures non-invasive medical devices.

Medical technology company Zynex updated its November orders, fourth-quarter estimate and a loan forbearance agreement. Read More »

Pernix appoints Leung to board of directors

American Pharmacy News Reports | Jan 4, 2017
Pernix Therapeutics Holdings specializes in pain and central nervous system conditions.

Pernix Therapeutics Holdings Inc., a pharmaceutical company specializing in pain and central nervous system conditions, recently appointed Gabriel Leung to its board of directors. Read More »

Bayer, Leica Biosystems to develop companion tests for cancer patients

Mark Iandolo | Jan 4, 2017
The tests will be based on the Bayer-developed automated BOND technology platform for novel targeted anti-cancer therapies.

Bayer recently announced an agreement with Leica Biosystems to collaborate on developing companion diagnostic tests based on tissue samples for cancer patients. Read More »

Express Scripts slated to present at health care summit

Carol Ostrow | Jan 5, 2017

The Express Scripts Holding Company recently revealed plans to present at the J.P. Morgan Healthcare Conference next week in San Francisco. Read More »

Genentech study analyzing emicizumab for hemophilia A meets primary endpoint

American Pharmacy News Reports | Jan 7, 2017
Emicizumab prophylaxis significantly reduced the number of bleeds over time in people in this difficult-to-treat setting.

Genentech, a member of the Roche Group, recently announced that the primary endpoint for the Phase III HAVEN 1 study has been met. The study evaluates emicizumab prophylaxis in people 12 years of age or older with hemophilia A and inhibitors to factor VIII. Read More »

Aurinia partners with Lonza for the manufacture of voclosporin

American Pharmacy News Reports | Jan 7, 2017
Lonza will provide Aurinia with cGMP-grade voclosporin drug substance for use in Aurinia’s Phase III lupus nephritis clinical program.

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, recently partnered with Lonza for the manufacture of voclosporin active pharmaceutical ingredient (API). Read More »

Direct Relief airlifts 82 tons of medical aid to Haiti

Mark Iandolo | Jan 7, 2017
Cholera and other diseases have become rampant across Haiti since Hurricane Matthew in October.

Direct Relief recently announced that it airlifted 82 tons of medical aid to Haiti for the treatment of cholera and other diseases that have become rampant since Hurricane Matthew in October. Read More »

Teva Pharmaceuticals agrees to pay $519 million settlement

Mark Iandolo | Jan 7, 2017
The settlement includes a penalty of $519 million.

Teva Pharmaceuticals Industries Ltd. (Teva) recently announced a settlement with the United States government related to allegations of violating the Foreign Corrupt Practices Act (FCPA) in Ukraine, Mexico and Russia. Read More »

AHSP applauds 21st Century Cures Act

American Pharmacy News Reports | Jan 7, 2017
The 21st Century Cures Act was enacted to change the way the United States treats disease.

The American Journal of Health-System Pharmacy has applauded the 21st Century Cures Act was signed into law by President Barack Obama on Dec. 13. Read More »

Medinol shares positive results in evaluation of EluNIR stent system

American Pharmacy News Reports | Jan 7, 2017
In the U.S. alone, over 700,000 patients undergo a coronary stenting procedure each year.

Medinol, a global Interventional Cardiology device company, recently announced positive twelve-month clinical results from its BIONICS study. The study was conducted to analyze and evaluate EluNIR, the company’s coronary stent system and the first ever elastomer-coated drug eluting stent (eDES). Read More »

CDC awards $184 million to fight Zika virus

American Pharmacy News Reports | Jan 8, 2017
CDC will use the remaining portion of the $350 million to continue its ongoing response to the Zika outbreak.

The Centers for Disease Control and Prevention has awarded $184 million in funding to various groups in an effort to protect Americans from Zika virus infection. Read More »

Endo International releases HCI generic injection drug in U.S.

American Pharmacy News Reports | Jan 8, 2017
HCI is the generic form of CellCept.

Endo International, PLC, a subsidiary of Par Pharmaceutical, recently released mycophenolate mofetil hydrochloride (HCI) in the U.S. following Food and Drug Administration approval of its Abbreviated New Drug Application. Read More »

  • «
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • ...
  • 36
  • 37
  • »
Trending

Dr. Allison Hill DC State Board of Pharmacy Chairperson

Modified services and closures announced for DC Emancipation Day observance

 Jeff Harrell Board President

Arkansas law bans PBMs from pharmacy ownership to curb anti-competitive practices

Shaun Noorian, Founder, CEO & Chairman, Empower Pharmacy

Empower Pharmacy ranks among fastest-growing private firms in Southwest

 Jeff Harrell Board President

NCPA reacts to Trump's drug pricing executive order targeting pharmacy benefit managers

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up